Stratec Biomedical AG STRATEC BIO.../ DE000STRA555 /
15/11/2024 17:00:12 | Chg. +0.60 | Volume | Bid- | Ask- | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
29.50EUR | +2.08% | 58 Turnover: 1,726.15 |
-Bid Size: - | -Ask Size: - | 353.74 mill.EUR | 1.89% | 27.20 |
Assets
2012 IFRS in mill. EUR |
2013 IFRS in mill. EUR |
2014 IFRS in mill. EUR |
2015 IFRS in mill. EUR |
2016 IFRS in mill. EUR |
|||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Property and Equipment | 17.1000 | 17 | 16 | 19.6000 | 32.8000 | ||||||
Intangible Assets | 6.2000 | 25.8000 | 25.5000 | 25.9000 | 75.9000 | ||||||
Long-Term Investments | .4000 | .4000 | .3000 | .2000 | .4000 | ||||||
Fixed Assets | - | - | - | - | - | ||||||
Inventories | 44.1000 | 18.1000 | 18.1000 | 16 | 24.5000 | ||||||
Accounts Receivable | 23.8000 | 23.4000 | 19 | 24 | 38.9000 | ||||||
Cash and Cash Equivalents | 13.2000 | 20.7000 | 46.6000 | 56.4000 | 26.5000 | ||||||
Current Assets | 92.4000 | 69.3000 | 90 | 108.1000 | 105.9000 | ||||||
Total Assets | 121.8000 | 117.8000 | 137.7000 | 158.9000 | 258 |
Liabilities
2012 IFRS in mill. EUR |
2013 IFRS in mill. EUR |
2014 IFRS in mill. EUR |
2015 IFRS in mill. EUR |
2016 IFRS in mill. EUR |
|||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Accounts Payable | 4.3000 | 4.4000 | 2.8000 | 3.4000 | 7.1000 | ||||||
Long-term debt | 7.5000 | 6.6000 | 4.5000 | 4.3000 | 3 | ||||||
Liabilities to Banks | 8.7000 | 8.5000 | 6.9000 | 8.1000 | 75.8000 | ||||||
Provisions | 2.9000 | 3 | 8.7000 | 8.6000 | 16.4000 | ||||||
Liabilities | 29.8000 | 20.6000 | 25.7000 | 28.7000 | 114.3000 | ||||||
Share Capital | 11.7000 | 11.8000 | 11.7950 | 11.8530 | 11.8610 | ||||||
Total Equity | 92 | 97.2000 | 112.1000 | 130.3000 | 143.7000 | ||||||
Minority Interests | - | - | - | - | - | ||||||
Total liabilities equity | 121.8000 | 117.8000 | 137.7000 | 158.9000 | 258 |
Income Statement
2012 IFRS in mill. EUR |
2013 IFRS in mill. EUR |
2014 IFRS in mill. EUR |
2015 IFRS in mill. EUR |
2016 IFRS in mill. EUR |
|||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Revenues | 122.4000 | 128 | 144.9000 | 146.9000 | 184.9000 | ||||||
Depreciation (total) | - | - | - | - | - | ||||||
Operating Result | 17.6000 | 19.5000 | 24.1000 | 26.9000 | 24.2000 | ||||||
Interest Income | -.1000 | 0.0000 | 0.0000 | .2000 | -.9200 | ||||||
Income Before Taxes | 17.4000 | 19.3000 | 24.1000 | 27.2000 | 22.9000 | ||||||
Income Taxes | 3.3000 | 2.8000 | .4000 | 4 | 6.5000 | ||||||
Minority Interests Profit | - | - | - | - | - | ||||||
Net Income | 14 | 15.5000 | 19.8000 | 22.1000 | 19.6000 |
Per Share
Cash Flow
2012 IFRS in mill. EUR |
2013 IFRS in mill. EUR |
2014 IFRS in mill. EUR |
2015 IFRS in mill. EUR |
2016 IFRS in mill. EUR |
|||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Cash Flow from Operating Activities | 2.7000 | 23.8000 | 39.8000 | 26 | 16.3000 | ||||||
Cash Flow from Investing Activities | -2.4000 | -10.3000 | -6.8000 | -8.7000 | -86.7000 | ||||||
Cash Flow from Financing | -6.8000 | -5.8000 | -8 | -8.7000 | 40.6000 | ||||||
Decrease / Increase in Cash | -6.5000 | 7.7000 | 24.9000 | 8.7000 | -29.9000 | ||||||
Employees | 496 | 537 | 540 | 583 | 976 |